Page last updated: 2024-09-04

ampelopsin and Acute Disease

ampelopsin has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jia, R; Ma, J; Meng, W; Wang, N1
Li, H; Miu, J; Sun, X; Xiao, P; Xu, L; Yu, F1

Other Studies

2 other study(ies) available for ampelopsin and Acute Disease

ArticleYear
Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response.
    Biochemical and biophysical research communications, 2018, 09-10, Volume: 503, Issue:3

    Topics: Acute Disease; Animals; Cell Death; Cell Survival; Cells, Cultured; Ceruletide; Cytokines; Flavonols; Macrophages; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Signal Transduction; TNF Receptor-Associated Factor 3

2018
Dihydromyricetin ameliorates memory impairment induced by acute sleep deprivation.
    European journal of pharmacology, 2019, Jun-15, Volume: 853

    Topics: Acute Disease; Animals; Flavonols; Maze Learning; Memory Disorders; Mice; Neuronal Plasticity; Oxidative Stress; Sleep Deprivation

2019